Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6.

MLA

Dauriz, Marco, et al. “Interleukin-6 as a Potential Positive Modulator of Human Beta-Cell Function: An Exploratory Analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6.” Acta Diabetologica, vol. 53, no. 3, June 2016, pp. 393–402. EBSCOhost, https://doi.org/10.1007/s00592-015-0807-z.

APA

Dauriz, M., Trombetta, M., Boselli, L., Santi, L., Brangani, C., Pichiri, I., Bonora, E., & Bonadonna, R. C. (2016). Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6. Acta Diabetologica, 53(3), 393–402. https://doi.org/10.1007/s00592-015-0807-z

Chicago

Dauriz, Marco, Maddalena Trombetta, Linda Boselli, Lorenza Santi, Corinna Brangani, Isabella Pichiri, Enzo Bonora, and Riccardo C Bonadonna. 2016. “Interleukin-6 as a Potential Positive Modulator of Human Beta-Cell Function: An Exploratory Analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6.” Acta Diabetologica 53 (3): 393–402. doi:10.1007/s00592-015-0807-z.